Collectively, these data indicate that sustained downregulation of PDCD4 during thyroid cancer dedifferentiation is associated with enhanced M2‐like macrophage infiltration and immunosuppressive remodeling, potentially driving tumor progression. Here, PDCD4 is linked to neoplasm.